New Zealand Electrical Stock News

Spark New Zealand recently reduced its dividend to better match lower profitability amid softer economic conditions, prompting investors to reassess the reliability of its cash returns. The company is emphasising stabilising earnings and expanding its data centre and digital infrastructure operations, signalling a shift in how future dividends may be supported. We’ll now examine how Spark’s dividend reset, and its push into data centre and digital infrastructure growth, affect the existing...

As of June 2026, Asian markets are navigating a complex landscape marked by mixed economic signals and geopolitical tensions. Despite these challenges, opportunities remain for investors willing to explore beyond the established giants. Penny stocks, often representing smaller or newer companies, continue to capture attention due to their potential for significant returns when backed by strong financials. In this article, we explore three such stocks that stand out for their balance sheet...

Why Mainfreight’s latest earnings and cash distribution matter for investors Mainfreight (NZSE:MFT) has drawn fresh attention after releasing full year results to 31 March 2026, with higher sales alongside lower net income, and confirming a final cash distribution to shareholders. See our latest analysis for Mainfreight. The stock’s 1 month share price return of 6.86% contrasts with a year to date share price return that is down 7.82%, while the 1 year total shareholder return is down 7.48%...

Promisia Healthcare Limited's ( NZSE:PHL ) stock was strong after they recently reported robust earnings. However, we...

EBOS Group (NZSE:EBO) is back in focus after analysts maintained a Buy stance on the stock while the company reported higher quarterly revenue and net profit compared with the same period a year earlier. See our latest analysis for EBOS Group. The recent analyst support and quarterly results come after a tough run for investors, with the share price down 29.1% year to date and the 1 year total shareholder return declining 46.2%. This suggests sentiment is still rebuilding despite the latest...

Global markets have recently been buoyed by optimism surrounding a potential U.S.-Iran peace agreement, which has driven several major U.S. stock indexes to record highs, supported by falling oil prices and enthusiasm for AI-linked stocks. In this context of heightened investor sentiment, penny stocks continue to capture attention as they offer an intriguing mix of affordability and growth potential. Despite their name suggesting a bygone era, penny stocks can still provide significant...

Earnings and dividend update for Fisher & Paykel Healthcare Fisher & Paykel Healthcare (NZSE:FPH) has released its full year results to 31 March 2026 alongside a dividend update, giving investors detail on both recent profitability and upcoming cash returns. The company reported sales of NZ$2,308.4m and net income of NZ$468.5m for the year, with basic earnings per share from continuing operations of NZ$0.798 and diluted earnings per share of NZ$0.793. Alongside earnings, Fisher & Paykel...

Global markets have been buoyed by hopes for a U.S.-Iran peace agreement, with major indices like the Nasdaq Composite and S&P 500 reaching record highs, driven in part by optimism around AI-linked stocks. Amid these developments, investors are increasingly looking beyond established giants to explore opportunities in smaller or newer companies. Penny stocks, despite their somewhat antiquated name, remain a relevant investment area offering potential for significant returns when backed by...

A lackluster earnings announcement from Turners Automotive Group Limited ( NZSE:TRA ) last week didn't sink the stock...

ikeGPS Group Limited ( NZSE:IKE ) last week reported its latest annual results, which makes it a good time for...

Fisher & Paykel Healthcare recently reported full-year results to March 31, 2026, with sales rising to NZ$2,308.4 million and net income reaching NZ$468.5 million, alongside basic earnings per share of NZ$0.798. The company also declared a six‑month dividend of NZ$0.38823529 per share, highlighting a continued focus on returning cash to shareholders as earnings grow. We’ll now examine how this stronger full-year profitability, alongside the increased dividend, shapes Fisher & Paykel...

ikeGPS Group (NZSE:IKE) has posted its FY 2026 first half numbers with revenue of NZ$12.8 million and a loss of NZ$4.4 million, equivalent to EPS of NZ$0.03. The company has seen revenue move from NZ$12.2 million in the first half of FY 2025 to NZ$12.8 million in the first half of FY 2026, while losses shifted from NZ$7.1 million to NZ$4.4 million over the same periods, setting up a results season where investors are watching how quickly the loss profile could narrow. With the stock trading...

Green Cross Health (NZSE:GXH) has kicked off FY 2026 with first half revenue of NZ$264.4 million and basic EPS of NZ$0.05, set against trailing 12 month revenue of NZ$546.0 million and EPS of NZ$0.1419 that reflects 27.7% year on year earnings growth and a net profit margin of 3.7%. Over the past two reported half years, revenue has moved from NZ$259.9 million in 1H FY 2025 to NZ$263.9 million in 2H FY 2025 and now NZ$264.4 million in 1H FY 2026, while basic EPS has shifted from NZ$0.0393 to...

Mainfreight (NZSE:MFT) has opened FY 2026 with first half revenue of NZ$2.6b and basic EPS of NZ$0.93, setting the tone for how its freight and logistics operations are translating into earnings power. The company has seen revenue move from NZ$2.6b in 1H FY 2025 to NZ$2.7b in 2H FY 2025 and NZ$2.6b in 1H FY 2026, while EPS shifted from NZ$1.14 to NZ$1.59 over FY 2025 halves before landing at NZ$0.93 in the latest period. This gives investors a clearer view of how volumes and pricing are...

Readers hoping to buy My Food Bag Group Limited ( NZSE:MFB ) for its dividend will need to make their move shortly, as...

Following the solid earnings report from AFT Pharmaceuticals Limited ( NZSE:AFT ), the market responded by bidding up...

Why Ryman Healthcare’s latest earnings are back in focus Ryman Healthcare (NZSE:RYM) has moved back onto investor watchlists after releasing full year results that combined higher revenue, a smaller reported net loss and positive free cash flow for the first time in over a decade. See our latest analysis for Ryman Healthcare. The NZ$2.28 share price has seen a sharp 7 day share price return of 11.22% and a 30 day share price return of 5.07%. However, this sits against a year to date share...

It's been a pretty great week for Fisher & Paykel Healthcare Corporation Limited ( NZSE:FPH ) shareholders, with its...

Shareholders in Infratil Limited ( NZSE:IFT ) may be thrilled to learn that the analysts have just delivered a major...

Ryman Healthcare (NZSE:RYM) has reported its FY 2026 first half with revenue of NZ$413.5 million and a basic EPS loss of NZ$0.04, while trailing 12 month figures show revenue of NZ$855.6 million and a basic EPS loss of NZ$0.17 as the company works through a period of weaker profitability. The company has seen revenue move from NZ$365.2 million in the first half of FY 2025 to NZ$394.0 million in the second half and now NZ$413.5 million in the first half of FY 2026, with EPS swinging from a...

New Zealand King Salmon Investments Limited ( NZSE:NZK ), might not be a large cap stock, but it led the NZSE gainers...

Fisher & Paykel Healthcare (NZSE:FPH) has opened FY 2026 with first half revenue of NZ$1.1b and basic EPS of NZ$0.36, setting the tone for investors focused on how its profit engine is tracking. The company has seen revenue move from NZ$951.2m and EPS of NZ$0.26 in the first half of FY 2025 to NZ$1.1b and EPS of NZ$0.36 in the latest half, with trailing 12 month EPS reaching NZ$0.80 alongside a net profit margin of 20.2% versus 9.4% a year earlier. This puts profitability firmly in focus as...

Infratil (NZSE:IFT) has opened FY 2026 with first half revenue of NZ$1.99b and basic EPS of NZ$0.33, putting fresh earnings figures in front of investors at a current share price of NZ$15.17. The company has seen revenue move from NZ$1.48b in the first half of FY 2025 to NZ$1.99b in the first half of FY 2026, while basic EPS has shifted from a loss of NZ$0.29 to a profit of NZ$0.33. This frames a clear swing in per share results. Overall, the latest numbers point to firmer margins, with...

EROAD (NZSE:ERD) has just posted its FY 2026 first half numbers, with revenue of NZ$99.1 million and a reported loss of NZ$144.2 million, which translated into EPS of NZ$0.77 loss per share. Over recent periods, revenue has moved from NZ$95.9 million in FY 2025 first half to NZ$98.5 million in FY 2025 second half and NZ$99.1 million in FY 2026 first half, while EPS has ranged from a loss of NZ$0.01 per share in FY 2025 first half to a profit of NZ$0.02 per share in FY 2025 second half before...